FANJ
ALXN

Financial Architects (New Jersey)’s Alexion Pharmaceuticals ALXN Stock Holding History

Financial Architects (New Jersey)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14
Closed -$2K – 1231
2019
Q2 		$2K Sell
14
-57
-80% -$7.35K ﹤0.01% 1113
2019
Q1 		$10K Sell
71
-6,294
-99% -$783K ﹤0.01% 1098
2018
Q4 		$620K Buy
6,365
+6,300
+9,692% +$745K 0.12% 132
2018
Q3 		$9K Buy
65
+11
+20% +$1.38K ﹤0.01% 1147
2018
Q2 		$7K Sell
54
-3,500
-98% -$409K ﹤0.01% 1080
2018
Q1 		$396K Buy
3,554
+3,518
+9,772% +$420K 0.08% 186
2017
Q4 		$4K Sell
36
-90
-71% -$11K ﹤0.01% 1355
2017
Q3 		$18K Buy
126
+100
+385% +$13.6K ﹤0.01% 983
2017
Q2 		$3K Sell
26
-15
-37% -$1.75K ﹤0.01% 1400
2017
Q1 		$5K Buy
41
+9
+28% +$1.16K ﹤0.01% 1302
2016
Q4 		$4K Buy
32
+7
+28% +$857 ﹤0.01% 1209
2016
Q3 		$3K Sell
25
-37
-60% -$4.76K ﹤0.01% 1288
2016
Q2 		$7K Sell
62
-4
-6% -$568 ﹤0.01% 1062
2016
Q1 		$9K Buy
+66
New +$9.69K ﹤0.01% 788
2015
Q3 		– Sell
-57
Closed -$10K – 1018
2015
Q2 		$10K Hold
57
– – ﹤0.01% 806
2015
Q1 		$10K Hold
57
– – ﹤0.01% 727
2014
Q4 		$11K Sell
57
-174
-75% -$32.2K ﹤0.01% 657
2014
Q3 		$20K Buy
231
+174
+305% +$28.6K 0.01% 475
2014
Q2 		$9K Buy
+57
New +$9K ﹤0.01% 670

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Financial Architects (New Jersey)'s ALXN Position: Q3 2019 in Review

Financial Architects (New Jersey) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 14 shares — an estimated $2K sold.

Financial Architects (New Jersey) first reported a position in ALXN in Q2 2014 and held it in 19 quarters. The position peaked at $620K in Q4 2018. 648 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

  • Financial Architects (New Jersey) reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 14 Alexion Pharmaceuticals shares in Q3 2019, an estimated $2K.
  • Financial Architects (New Jersey) first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 19 quarters.
  • Financial Architects (New Jersey)'s Alexion Pharmaceuticals position peaked at $620K in Q4 2018.
  • 648 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2019, filed 6 Nov 2019.